Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

Journal Article (Clinical Trial;Letter)

Full Text

Duke Authors

Cited Authors

  • Storb, R; Pepe, M; Deeg, HJ; Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Doney, K; Hansen, J

Published Date

  • July 15, 1992

Published In

Volume / Issue

  • 80 / 2

Start / End Page

  • 560 - 561

PubMed ID

  • 1627810

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • eng

Conference Location

  • United States